Загрузка...
Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release
It has been previously reported that HSP27 is released from platelets in type 2 diabetes mellitus (DM) patients according to phosphorylation. In the present study, we investigated the effect of ristocetin, a glycoprotein (GP)Ib/IX/V activator, on the release of HSP27 and the effect of anti-platelet...
Сохранить в:
| Опубликовано в: : | Biomed Rep |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5838301/ https://ncbi.nlm.nih.gov/pubmed/29541457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2018.1058 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|